Bodenstedt Matthias bought MLTX
October 8, 2025 · Form 4 insider transaction
Bodenstedt Matthias bought 10,870 shares of MoonLake Immunotherapeutics at $9.09 per share, a transaction worth $98.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,870
Price
$9.09
Total value
$98.8K
InsiderBodenstedt Matthias
Role—
SecurityClass A ordinary shares, par value $0.0001 per share
Transaction codeP: Open-market purchase
Transaction dateOctober 8, 2025
Filing dateOctober 9, 2025
Shares owned after627,536
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.